Browsing Topic

Recce stocks

1 post
The Market Online Video

Recce completes cohort dosing for Phase I/II UTI/Urosepsis Rapid Infusion Clinical Trial with fastest infusion times yet; key safety review inbound

Recce Pharmaceuticals (ASX:RCE) has confirmed its completion of the latest study using its R327 anti-infective as…
  • 2 mins
  • 11 June 2024 09:38 (AEDT)